Patient characteristics |
Provider/system/treatment characteristics (continued) |
Sex, age, race |
|
Education |
Duration of treatment (past and expected) |
Socio-economic status |
Complexity of administration |
Knowledge |
Accessibility and cohesion of services |
Perceived need for treatment (insight) |
Access to care |
Motivation |
Continuity of care |
Beliefs about treatment risks and benefits |
Reimbursement |
Past experiences/"transference" |
Ability to monitor adherence |
Past history of adherence |
Provision of psychoeducation |
Self-stigma |
Availability of trained psychosocial treatment specialists |
Illness characteristics |
Evaluation of obstacles to adherence |
Illness duration (first episode, chronic) |
Access to alternative formulations (e.g., long-acting injectable antipsychotics) |
Illness phase (acute, maintenance, etc.) |
Complexity of administration |
Symptom type and severity (e.g., negative symptoms, depression, demoralization) |
|
|
Family/caregiver characteristics |
Cognitive function |
Nature of relationship |
Lack of insight |
Perceived need for treatment (insight) |
Substance use |
Beliefs about treatment risks and benefits |
Comorbidities |
Knowledge, beliefs, attribution |
Degree of refractoriness |
Involvement in psychoeducation |
Potential for relatively asymptomatic intervals or "spontaneous remission" |
Involvement in adherence monitoring |
|
Stigma |
Medication characteristics |
|
Efficacy (consider different domains) |
Environmental characteristics |
Effectiveness |
Physical environment |
Adverse effects (of relevance for the patient) |
Level of supervision |
Delivery systems/formulation |
Orderliness |
Dosage frequency |
Safety and privacy |
Cost/access |
Stigma |
|
Extrafamilial support system |
Provider/system/treatment characteristics |
Other resource characteristics |
Therapeutic alliance |
Financial |
Frequency and nature of contact with clinicians |
Transportation |